Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot Study
| Status: | Withdrawn |
|---|---|
| Conditions: | Neurology, Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 11/3/2017 |
| Start Date: | May 2013 |
| End Date: | May 2013 |
Pilot Study of Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage
The purpose of this study is to determine the feasibility of prospectively enrolling and
randomizing patients with aneurysmal subarachnoid hemorrhage (aSAH) to receive levetiracetam
or not to receive levetiracetam, and documenting in-hospital and follow-up clinical
variables.
randomizing patients with aneurysmal subarachnoid hemorrhage (aSAH) to receive levetiracetam
or not to receive levetiracetam, and documenting in-hospital and follow-up clinical
variables.
Inclusion Criteria:
- ≥ 18 years of age
- ≤ 75 years of age
- Newly diagnosed aneurysmal subarachnoid hemorrhage
Exclusion Criteria:
- One or more antiepileptic medication is taken as a pre-admission medication
- Seizure occurrence in the field or in the emergency department, or anytime before
consent could be obtained
- Inability to obtain informed consent from the patient, or from the patient's
appropriate surrogate
We found this trial at
1
site
1211 Medical Center Dr
Nashville, Tennessee 37232
Nashville, Tennessee 37232
(615) 322-5000
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
Click here to add this to my saved trials
